Posts Tagged ‘Netherlands life sciences’
Cost Control in GMP Projects: How Structured Project Consultancy Protects Budgets
A Conversation That we are Stuck With A few months ago, while we were speaking with someone managing a facility expansion for a biotechnology company here in the Netherlands. The project looked well organized. Budget approved. Timeline agreed. Engineering plans already signed off. Everything seemed fairly stable. Then things began to shift. A supplier updated…
Read MoreHow Dutch Pharma Companies Can De-Risk CAPEX Projects Through Structured Consultancy Models
Why CAPEX Projects in Dutch Pharma Are Becoming Harder and What Companies are Doing About It A few months ago, we were speaking with someone leading a facility expansion project for a pharmaceutical company in the Netherlands. The conversation started the way these conversations usually do timelines, construction phases, equipment delivery schedules. Dutch Pharma CAPEX…
Read MoreThe Hidden Cost of Leadership Vacancies in High-Growth Life Sciences Companies
Growth Is Strong in the Netherlands. Leadership Gaps Are Not. The Netherlands has built one of Europe’s most competitive innovation ecosystems. But leadership vacancies in Netherlands life sciences companies are becoming an increasingly underestimated risk to growth. In high-growth biotech and pharmaceutical organizations, an executive gap is rarely just an HR issue, it is a…
Read More